Jiangsu Cancer Institute & Hospital

This study is testing whether adding an immunotherapy drug called sintilimab to standard chemotherapy before radiation treatment helps people with inoperable esophageal cancer live longer and keeps the cancer from coming back. Researchers will compare this new combination approac…